We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENS icon
726
EnerSys
ENS
$6.99B
$1.1M 0.01%
+16,015
New +$1.05M
HCSG icon
727
Healthcare Services Group
HCSG
$1.53B
$1.08M 0.01%
35,762
+26,610
+291% +$879K
PRGS icon
728
Progress Software
PRGS
$1.76B
$1.08M 0.01%
24,832
+24,205
+3,860% +$1.05M
NVRI icon
729
Enviri
NVRI
$620M
$1.08M 0.01%
39,368
+12,729
+48% +$311K
AZTA icon
730
Azenta
AZTA
$1.48B
$1.08M 0.01%
27,778
+24,984
+894% +$896K
PFPT
731
DELISTED
Proofpoint, Inc.
PFPT
$1.07M 0.01%
+8,917
New +$1.05M
AZO icon
732
AutoZone
AZO
$51.1B
$1.07M 0.01%
971
+787
+428% +$828K
STOK icon
733
Stoke Therapeutics
STOK
$2.11B
$1.06M 0.01%
+36,355
New +$976K
HRC
734
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$1.06M 0.01%
10,132
-4,123
-29% -$417K
COLM icon
735
Columbia Sportswear
COLM
$2.94B
$1.05M 0.01%
10,504
-176,032
-94% -$17.5M
SMTC icon
736
Semtech
SMTC
$13B
$1.05M 0.01%
+21,876
New +$1.06M
ATRO icon
737
Astronics
ATRO
$3.84B
$1.05M 0.01%
+31,224
New +$981K
AKRO
738
DELISTED
Akero Therapeutics
AKRO
$1.04M 0.01%
+54,304
New +$1.03M
PLMR icon
739
Palomar
PLMR
$3.45B
$1.04M 0.01%
+43,164
New +$950K
MLKN icon
740
MillerKnoll
MLKN
$1.67B
$1.03M 0.01%
+22,972
New +$869K
DHC
741
Diversified Healthcare Trust
DHC
$2.14B
$1.02M 0.01%
123,778
+105,451
+575% +$878K
RCM
742
DELISTED
R1 RCM Inc. Common Stock
RCM
$1.02M 0.01%
81,410
+80,358
+7,639% +$908K
SPSC icon
743
SPS Commerce
SPSC
$2.64B
$1.02M 0.01%
+19,992
New +$1.04M
ADSW
744
DELISTED
Advanced Disposal Services Inc
ADSW
$1.02M 0.01%
+32,027
New +$1.01M
CASY icon
745
Casey's General Stores
CASY
$30.9B
$1.02M 0.01%
+6,539
New +$892K
PNC icon
746
PNC Financial Services
PNC
$101B
$1.02M 0.01%
7,432
-95,758
-93% -$12.7M
BIDU icon
747
Baidu
BIDU
$37.2B
$1.01M 0.01%
8,617
+2,523
+41% +$359K
MMM icon
748
3M
MMM
$94.3B
$1.01M 0.01%
+6,973
New +$1.07M
KRTX
749
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.01M 0.01%
+50,325
New +$1.01M
CTB
750
DELISTED
Cooper Tire & Rubber Co.
CTB
$1M 0.01%
+31,685
New +$963K
28 29
30
31 32

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.